Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 31 tags : Europe save search
BeyondSpring Announces Late-Breaking Oral Presentation of Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination Versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncology 2021 Congress
Published: 2021-08-31 (Crawled : 15:00) - beyondspringpharma.com
BYSI | $2.46 7.42% 6.91% 97K
|
Health Technology
|
| O: 0.25%
H: 19.31%
C: 13.2%
presentation lung cancer europe cancer phase 3 plinabulin
Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS
Published: 2021-08-31 (Crawled : 14:00) - biospace.com/
SNN | $24.57 -0.93% 0.0% 1.2M
|
Health Technology
|
| O: -0.13%
H: 0.49%
C: -0.16%
acquired aβos
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology
Published: 2021-08-31 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -1.81%
europe cardiology test vascepa research cardio
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.